Literature DB >> 4061651

Factors influencing triacylglycerol delivery into mesenteric lymph.

C M Mansbach, A Arnold, M A Cox.   

Abstract

The transport of triacylglycerol (TG) in mesenteric lymph was studied in rats with duodenal and mesenteric lymphatic cannulas with or without bile fistulas. Rats were infused with 135 mumol glycerol trioleate (TO) for 4 h, followed by 5 h of NaCl infusion. Rats with intact fistulas prefed 20% corn oil had nearly twice the maximum output of TG in lymph as controls. Decay from peak values was zero order for controls and indeterminate for rats prefed corn oil. In rats with bile fistulas, less TG was transported in lymph than in those in which 2 mM phosphatidylcholine (PC) was added to the infusate. The decay from maximum values was zero order for controls and first order for rats infused with PC and TO. Recovery of infused [3H]glycerol trioleate in controls was 43% and increased to 68% on inclusion of PC in the infusate. We conclude that in chow-fed rats lymph TG delivery rates were well below infusion rates, suggesting alternate TG transport routes, TG transport was improved by supplementing the infusate with PC or prefeeding with 20% TG in chow, and PC may be limiting in TG transport in rats with bile fistulas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4061651     DOI: 10.1152/ajpgi.1985.249.5.G642

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Relationship of phosphatidylcholine to hydrophobic surfactant on rat intestinal chylomicron secretion.

Authors:  J B Rodgers; D A Beeler; P Tso
Journal:  Experientia       Date:  1996-07-15

2.  Bile increases intestinal lymphatic drug transport in the fasted rat.

Authors:  Natalie L Trevaskis; Christopher J H Porter; William N Charman
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

3.  Regulation of intestinal apolipoprotein A-I synthesis by dietary phosphatidylcholine in newborn swine.

Authors:  H Wang; J Du; S Lu; Y Yao; F Hunter; D D Black
Journal:  Lipids       Date:  2001-07       Impact factor: 1.880

4.  An acute and coincident increase in FABP expression and lymphatic lipid and drug transport occurs during intestinal infusion of lipid-based drug formulations to rats.

Authors:  Natalie L Trevaskis; Chun Min Lo; Li Yun Ma; Patrick Tso; Helen R Irving; Christopher J H Porter; William N Charman
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

5.  Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats.

Authors:  Ditte M Karpf; René Holm; Henning G Kristensen; Anette Müllertz
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

6.  Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs.

Authors:  Shui-Mei Khoo; David M Shackleford; Christopher J H Porter; Glenn A Edwards; William N Charman
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

7.  Milk Fat Globule structure & function; nanosciece comes to milk production.

Authors:  Nurit Argov; Danielle G Lemay; J Bruce German
Journal:  Trends Food Sci Technol       Date:  2008-12       Impact factor: 12.563

8.  Phospholipids affect the intestinal absorption of carotenoids in mice.

Authors:  Vallikannan Baskaran; Tatsuya Sugawara; Akihiko Nagao
Journal:  Lipids       Date:  2003-07       Impact factor: 1.880

9.  Lysophosphatidylcholine increases the secretion of cholesteryl ester-poor triacylglycerol-rich lipoproteins by CaCo-2 cells.

Authors:  F J Field; E Born; H Chen; S Murthy; S N Mathur
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

10.  Lysophosphatidylcholine for efficient intestinal lipid absorption and lipoprotein secretion in caco-2 cells.

Authors:  Takanari Nakano; Ikuo Inoue; Shigehiro Katayama; Makoto Seo; Seiichiro Takahashi; Shigeru Hokari; Rina Shinozaki; Kazuhisa Hatayama; Tsugikazu Komoda
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.